These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 20516217)

  • 1. Sphingosine kinase 1 induces tolerance to human epidermal growth factor receptor 2 and prevents formation of a migratory phenotype in response to sphingosine 1-phosphate in estrogen receptor-positive breast cancer cells.
    Long JS; Edwards J; Watson C; Tovey S; Mair KM; Schiff R; Natarajan V; Pyne NJ; Pyne S
    Mol Cell Biol; 2010 Aug; 30(15):3827-41. PubMed ID: 20516217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine 1-phosphate receptor 4 uses HER2 (ERBB2) to regulate extracellular signal regulated kinase-1/2 in MDA-MB-453 breast cancer cells.
    Long JS; Fujiwara Y; Edwards J; Tannahill CL; Tigyi G; Pyne S; Pyne NJ
    J Biol Chem; 2010 Nov; 285(46):35957-66. PubMed ID: 20837468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients.
    Watson C; Long JS; Orange C; Tannahill CL; Mallon E; McGlynn LM; Pyne S; Pyne NJ; Edwards J
    Am J Pathol; 2010 Nov; 177(5):2205-15. PubMed ID: 20889557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2.
    Takabe K; Kim RH; Allegood JC; Mitra P; Ramachandran S; Nagahashi M; Harikumar KB; Hait NC; Milstien S; Spiegel S
    J Biol Chem; 2010 Apr; 285(14):10477-86. PubMed ID: 20110355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor-negative breast cancer.
    Ohotski J; Long JS; Orange C; Elsberger B; Mallon E; Doughty J; Pyne S; Pyne NJ; Edwards J
    Br J Cancer; 2012 Apr; 106(8):1453-9. PubMed ID: 22460268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic triple-negative breast cancer is dependent on SphKs/S1P signaling for growth and survival.
    Maiti A; Takabe K; Hait NC
    Cell Signal; 2017 Apr; 32():85-92. PubMed ID: 28108260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway.
    Alshaker H; Krell J; Frampton AE; Waxman J; Blyuss O; Zaikin A; Winkler M; Stebbing J; Yagüe E; Pchejetski D
    Breast Cancer Res; 2014 Oct; 16(5):426. PubMed ID: 25482303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of sphingosine-1-phosphate phosphatase 1 in epidermal growth factor-induced chemotaxis.
    Le Stunff H; Mikami A; Giussani P; Hobson JP; Jolly PS; Milstien S; Spiegel S
    J Biol Chem; 2004 Aug; 279(33):34290-7. PubMed ID: 15180992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel functional and spatial associations between sphingosine kinase 1, sphingosine 1-phosphate receptors and other signaling proteins that affect prognostic outcome in estrogen receptor-positive breast cancer.
    Ohotski J; Edwards J; Elsberger B; Watson C; Orange C; Mallon E; Pyne S; Pyne NJ
    Int J Cancer; 2013 Feb; 132(3):605-16. PubMed ID: 22733311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells.
    Berdyshev EV; Gorshkova IA; Usatyuk P; Zhao Y; Saatian B; Hubbard W; Natarajan V
    Cell Signal; 2006 Oct; 18(10):1779-92. PubMed ID: 16529909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular sphingosine kinase 2-derived sphingosine-1-phosphate mediates epidermal growth factor-induced ezrin-radixin-moesin phosphorylation and cancer cell invasion.
    Adada MM; Canals D; Jeong N; Kelkar AD; Hernandez-Corbacho M; Pulkoski-Gross MJ; Donaldson JC; Hannun YA; Obeid LM
    FASEB J; 2015 Nov; 29(11):4654-69. PubMed ID: 26209696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells.
    Nava VE; Hobson JP; Murthy S; Milstien S; Spiegel S
    Exp Cell Res; 2002 Nov; 281(1):115-27. PubMed ID: 12441135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine kinase as an oncogene: autocrine sphingosine 1-phosphate modulates ML-1 thyroid carcinoma cell migration by a mechanism dependent on protein kinase C-alpha and ERK1/2.
    Bergelin N; Blom T; Heikkilä J; Löf C; Alam C; Balthasar S; Slotte JP; Hinkkanen A; Törnquist K
    Endocrinology; 2009 May; 150(5):2055-63. PubMed ID: 19116345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Designed Small Molecule Inhibitor of a Non-Coding RNA Sensitizes HER2 Negative Cancers to Herceptin.
    Costales MG; Hoch DG; Abegg D; Childs-Disney JL; Velagapudi SP; Adibekian A; Disney MD
    J Am Chem Soc; 2019 Feb; 141(7):2960-2974. PubMed ID: 30726072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine kinase 2 prevents the nuclear translocation of sphingosine 1-phosphate receptor-2 and tyrosine 416 phosphorylated c-Src and increases estrogen receptor negative MDA-MB-231 breast cancer cell growth: The role of sphingosine 1-phosphate receptor-4.
    Ohotski J; Rosen H; Bittman R; Pyne S; Pyne NJ
    Cell Signal; 2014 May; 26(5):1040-7. PubMed ID: 24486401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factors mediate heterotrimeric G protein-dependent ERK1/2 activation by transactivating sphingosine 1-phosphate receptors.
    El-Shewy HM; Johnson KR; Lee MH; Jaffa AA; Obeid LM; Luttrell LM
    J Biol Chem; 2006 Oct; 281(42):31399-407. PubMed ID: 16926156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-density lipoprotein induced expression of connective tissue growth factor via transactivation of sphingosine 1-phosphate receptors in mesangial cells.
    El-Shewy HM; Sohn M; Wilson P; Lee MH; Hammad SM; Luttrell LM; Jaffa AA
    Mol Endocrinol; 2012 May; 26(5):833-45. PubMed ID: 22422617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fulvestrant regulates epidermal growth factor (EGF) family ligands to activate EGF receptor (EGFR) signaling in breast cancer cells.
    Zhang X; Diaz MR; Yee D
    Breast Cancer Res Treat; 2013 Jun; 139(2):351-60. PubMed ID: 23686416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer sphingosine-1-phosphate is associated with phospho-sphingosine kinase 1 and lymphatic metastasis.
    Tsuchida J; Nagahashi M; Nakajima M; Moro K; Tatsuda K; Ramanathan R; Takabe K; Wakai T
    J Surg Res; 2016 Sep; 205(1):85-94. PubMed ID: 27621003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-talk between sphingosine-1-phosphate and EGFR signaling pathways enhances human glioblastoma cell invasiveness.
    Cattaneo MG; Vanetti C; Samarani M; Aureli M; Bassi R; Sonnino S; Giussani P
    FEBS Lett; 2018 Mar; 592(6):949-961. PubMed ID: 29427528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.